SCHEMBL3306947

SCHEMBL3306947

COc1ccc(N=C=O)cc1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
CYP3A4 P08684 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
HPGD P15428 2/20 0.46
TRPA1 O75762 1/20 0.44
MAPK1 P28482 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
ERN1 O75460 2/20 0.41
PTGS1 P23219 2/20 0.41
PTGS2 P35354 1/20 0.41
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
GRIN3A Q8TCU5 1/20 0.40
TUBB1 Q9H4B7 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29600721 0.83 HTR3E (0.53) ALDH1A1CYP3A4TDP1HPGDTRPA1
SCHEMBL307695 0.83 HTR3E (0.53) ALDH1A1CYP3A4TDP1HPGDTRPA1
SCHEMBL6504746 0.81 MAPT (0.43) ALDH1A1CYP3A4TDP1HPGDTRPA1
SCHEMBL124245 0.80 CYP3A4 (0.59) ALDH1A1CYP3A4TDP1HPGDTRPA1
SCHEMBL29510769 0.80 CYP3A4 (0.59) ALDH1A1CYP3A4TDP1HPGDTRPA1
SCHEMBL12459048 0.79 ALDH1A1 (0.52) ALDH1A1HPGDMAPK1CYP1A2CYP2D6
SCHEMBL421340 0.79 TDP1 (0.61) ALDH1A1CYP3A4TDP1HPGDTRPA1
SCHEMBL8070390 0.79 CYP3A4 (0.46) ALDH1A1CYP3A4TDP1HPGDTRPA1
SCHEMBL8022333 0.79 ALDH1A1 (0.48) ALDH1A1CYP3A4TDP1HPGDTRPA1
SCHEMBL3977319 0.78 MAPK1 (0.40) CYP3A4TDP1TRPA1MAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9738661-B2 HCV NS3 protease inhibitors MERCK SHARP & DOHME CORP. (US) 2017-08-22 US disclosed
US-20150266897-A1 HCV NS3 Protease Inhibitors MSD ITALIA S.R.L. (IT) 2015-09-24 US disclosed
US-20100099695-A1 HCV NS3 Protease Inhibitors MSD ITALIA S.R.L. (IT) 2010-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099695-A1 HCV NS3 Protease Inhibitors HAVCR2, GTF3C3, CTSC ALDH1A1 1199/4885CYP3A4 154/4885TDP1 3107/4885
US-20150266897-A1 HCV NS3 Protease Inhibitors HAVCR2, GTF3C3, CTSC ALDH1A1 1199/4885CYP3A4 154/4885TDP1 3107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.